Additionally, although the mutation of TP53 is considered to be a key factor in the development of ESCC, we have not found that the expression of DR4 and DR5 was related to the mutation of TP53 in this study, neither did we investigate whether TP53 was one of targets of CPP. This evidence concerns the gene TNFRSF10A and esophageal squamous cell carcinoma.